Biodock vs Idexx Laboratories
Side-by-side comparison of AI visibility scores, market position, and capabilities
AI cloud computing platform for life sciences microscopy images and NGS sequencing data management; $2.1M a16z pre-seed backed YC W21 at $750K ARR serving biotech and academic research labs.
About
Biodock is a San Francisco-based AI cloud computing platform for life sciences research — providing data management, analysis, and collaboration infrastructure specifically designed for biological research data including microscopy images, next-generation sequencing (NGS) outputs, and other large-scale biological datasets that overwhelm general-purpose cloud storage and analytics tools. Founded in 2020 and backed by Andreessen Horowitz in a pre-seed round with $2.1-2.33 million raised, plus notable angel investors from Tiger Global and Flatiron Health, Biodock (YC W21) reached $750,000 in annual revenue as of June 2025.
Veterinary diagnostics leader with $3.81B FY2024 revenue; 130,000+ analyzer installed base; AI-powered inVue Dx digital cytology; VetConnect data platform; pet humanization tailwind.
About
IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headquartered. The company trades on Nasdaq (IDXX) and reported $3.81 billion in revenues for FY2024, maintaining its dominant position in point-of-care veterinary diagnostics through an installed base of over 130,000 Catalyst chemistry analyzers, ProCyte hematology systems, and SNAP rapid assay devices deployed in veterinary clinics worldwide. CEO Jay Mazelsky has continued IDEXX's expansion into AI-powered diagnostics and digital pathology, building on over four decades of veterinary-specific product development.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.